SG Americas Securities’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-765
| Closed | -$13K | – | 2900 |
|
|
2024
Q1 | $13K | Buy |
765
+13
| +2% | +$221 | ﹤0.01% | 2516 |
|
|
2023
Q4 | $12K | Sell |
752
-261
| -26% | -$4.17K | ﹤0.01% | 2711 |
|
|
2023
Q3 | $50K | Buy |
+1,013
| New | +$50K | ﹤0.01% | 2644 |
|
|
2023
Q2 | – | Sell |
-708
| Closed | -$64K | – | 2933 |
|
|
2023
Q1 | $64K | Buy |
708
+167
| +31% | +$15.1K | ﹤0.01% | 2756 |
|
|
2022
Q4 | $64K | Buy |
541
+1
| +0.2% | +$118 | ﹤0.01% | 2541 |
|
|
2022
Q3 | $98K | Sell |
540
-11
| -2% | -$2K | ﹤0.01% | 2565 |
|
|
2022
Q2 | $49K | Buy |
+551
| New | +$49K | ﹤0.01% | 2958 |
|
|
2021
Q4 | – | Sell |
-663
| Closed | -$382K | – | 3414 |
|
|
2021
Q3 | $382K | Buy |
663
+169
| +34% | +$97.4K | ﹤0.01% | 2515 |
|
|
2021
Q2 | $224K | Buy |
494
+48
| +11% | +$21.8K | ﹤0.01% | 2064 |
|
|
2021
Q1 | $240K | Buy |
+446
| New | +$240K | ﹤0.01% | 2323 |
|